Structure | Chemical Name | CAS | MF |
|
1-(3-FLUOROBENZYL)-1H-INDOLE-3-CARBALDEHYDE
|
347323-97-1
|
C16H12FNO
|
|
(2Z)-2-{[1-(4-chlorophenyl)-2,5-dimethyl-1H-pyrrol-3-yl]methylidene}[1,3]thiazolo[3,2-a]benzimidazol-3(2H)-one
|
347324-16-7
|
C22H16ClN3OS
|
|
3-BROMO-4-MORPHOLINOANILINE
|
347324-26-9
|
C10H13BrN2O
|
|
2-cyano-N-(2-thienylmethyl)acetamide
|
347324-95-2
|
C8H8N2OS
|
|
N-{[(3-acetylphenyl)amino]carbonothioyl}-4-chlorobenzamide
|
347327-69-9
|
C16H13ClN2O2S
|
|
1-(4-METHOXY-PHENYL)-2,5-DIMETHYL-1H-PYRROLE-3-CARBALDEHYDE
|
347331-30-0
|
C14H15NO2
|
|
1-(4-HYDROXY-PHENYL)-2,5-DIMETHYL-1H-PYRROLE-3-CARBALDEHYDE
|
347331-35-5
|
C13H13NO2
|
|
1-(4-ETHOXY-PHENYL)-2,5-DIMETHYL-1H-PYRROLE-3-CARBALDEHYDE
|
347331-41-3
|
C15H17NO2
|
|
(2,4-Dinitro-phenyl)-(tetrahydro-furan-2-ylmethyl)-amine
|
347331-76-4
|
C11H13N3O5
|
|
1-(4-BROMO-PHENYL)-2,5-DIMETHYL-1H-PYRROLE-3-CARBALDEHYDE
|
347331-78-6
|
C13H12BrNO
|
|
1-(4-BROMO-3-METHYLPHENYL)-2,5-DIMETHYL-1H-PYRROLE-3-CARBALDEHYDE
|
347331-84-4
|
C14H14BrNO
|
|
ASISCHEM R37030
|
347332-01-8
|
C15H15NO3
|
|
ASISCHEM R42205
|
347332-11-0
|
C17H15NO
|
|
3-(2-pyridin-2-ylethyl)aniline(SALTDATA: FREE)
|
347335-08-4
|
C13H14N2
|
|
4-Chloro-2-(p-tolyl)quinoline-1(2H)-carbaldehyde
|
347335-63-1
|
C17H14ClNO
|
|
N-{[(2-methoxyphenyl)amino]carbonothioyl}-2-furamide
|
347335-89-1
|
C13H12N2O3S
|
|
N-[3-(5,7-DICHLORO-1,3-BENZOXAZOL-2-YL)PHENYL]-1-BENZOFURAN-2-CARBOXAMIDE
|
347339-83-7
|
C22H12Cl2N2O3
|
|
N-[2-methoxy-4-(pentanoylamino)phenyl]-1-benzofuran-2-carboxamide
|
347340-05-0
|
C21H22N2O4
|
|
2-(4,6-DIAMINO-PYRIMIDIN-2-YLSULFANYL)-PROPIONIC ACID
|
347341-51-9
|
C7H10N4O2S
|
|
2-(6-METHYL-4-OXO-1,4-DIHYDRO-PYRIMIDIN-2-YLSULFANYL)-PROPIONIC ACID
|
347341-65-5
|
C8H10N2O3S
|
|
3-[BIS-(2-HYDROXY-ETHYL)-AMINO]-BENZOIC ACID
|
347343-88-8
|
C11H15NO4
|
|
5-Pyrimidinecarboxylicacid,1,2,3,4-tetrahydro-6-methyl-4-(4-methylphenyl)-2-oxo-,2-propenylester(9CI)
|
347351-41-1
|
C16H18N2O3
|
|
5-Pyrimidinecarboxylicacid,1,2,3,4-tetrahydro-6-methyl-2-oxo-4-phenyl-,1-methylpropylester(9CI)
|
347351-42-2
|
C16H20N2O3
|
|
N-CYCLOPROPYL-N-(2-NITRO-5-PIPERAZIN-1-YLPHENYL)AMINE
|
347353-82-6
|
C13H18N4O2
|
|
N1-(4-Nitro-2-trifluoromethyl-phenyl)-ethane-1,2-diamine
|
347355-57-1
|
C9H10F3N3O2
|
|
N-[2-(Acetylamino)ethyl]-4-amino-1,2,5-oxadiazole-3-carboxamide
|
347355-79-7
|
C7H11N5O3
|
|
2-METHYL-4-NITRO-5-PYRROLIDIN-1-YL-PHENYLAMINE
|
347355-84-4
|
C11H15N3O2
|
|
1-{5-amino-2-nitro-4-methylphenyl}-4-methylpiperazine
|
347355-95-7
|
C12H18N4O2
|
|
4-(6-{4-[(4-chlorophenyl)sulfonyl]piperazin-1-yl}pyridazin-3-yl)morpholine
|
347356-13-2
|
C18H22ClN5O3S
|
|
7-Hydroxymatairesinol-7-allo-Hydroxymatairesinol mixture
|
347359-71-1
|
C20H22O7
|
|
3-(trifluoromethyl)-1,4,5,6-tetrahydrocyclopenta[c]pyrazole
|
347361-46-0
|
C7H7F3N2
|
|
4,5,6,7-TETRAHYDRO-1-PHENYL-3-(TRIFLUOROMETHYL)-1H-INDAZOLE
|
347361-52-8
|
C14H13F3N2
|
|
1H-Pyrrole-2-carboxylic acid, 5-(chlorocarbonyl)-, methyl ester (9CI)
|
347362-31-6
|
C7H6ClNO3
|
|
8-ACETYLAMINO-3A,4,5,9B-TETRAHYDRO-3 H-CYCLOPENTA[ C ]QUINOLINE-4-CARBOXYLIC ACID
|
347362-65-6
|
C15H16N2O3
|
|
8-[(diisobutylamino)methyl]-7-hydroxy-3-(3-methylphenoxy)-2-(trifluoromethyl)-4H-chromen-4-one
|
347364-20-9
|
C26H30F3NO4
|
|
8-[(dimethylamino)methyl]-7-hydroxy-3-(1-naphthyl)-2-(trifluoromethyl)-4H-chromen-4-one
|
347364-30-1
|
C23H18F3NO3
|
|
3-chloro-1-(3-chlorophenyl)-4-(3-hydroxyanilino)-1H-pyrrole-2,5-dione
|
347364-42-5
|
C16H10Cl2N2O3
|
|
N-(4-methylphenyl)-2-[3-(4-morpholinylmethyl)-2,4-dioxo-1,3-thiazolidin-5-yl]acetamide
|
347364-48-1
|
C17H21N3O4S
|
|
1,1-DIOXO-4-PHENETHYLAMINO-TETRAHYDRO-1LAMBDA6-THIOPHEN-3-OL
|
347364-75-4
|
C12H17NO3S
|
|
4-(2-DIMETHYLAMINO-ETHYLAMINO)-1,1-DIOXO-TETRAHYDRO-1LAMBDA6-THIOPHEN-3-OL
|
347364-76-5
|
C8H18N2O3S
|
|
2-methyl-3-[(1,3,3-trimethyl-6-azabicyclo[3.2.1]oct-6-yl)methyl]-4-quinolinol
|
347364-79-8
|
C21H28N2O
|
|
3-[(dimethylamino)methyl]-2,6-dimethyl-4-quinolinol
|
347364-80-1
|
C14H18N2O
|
|
2,8-dimethyl-3-[(1,3,3-trimethyl-6-azabicyclo[3.2.1]oct-6-yl)methyl]-4-quinolinol
|
347364-83-4
|
C22H30N2O
|
|
3-chloro-1-(2,5-dichlorophenyl)-4-(methylanilino)-1H-pyrrole-2,5-dione
|
347365-49-5
|
C17H11Cl3N2O2
|
|
3-chloro-1-(5-chloro-2-methoxyphenyl)-4-(1-piperidinyl)-1H-pyrrole-2,5-dione
|
347365-78-0
|
C16H16Cl2N2O3
|
|
N-(1,3-benzothiazol-2-yl)-3-[4-(hexyloxy)-3-methoxyphenyl]acrylamide
|
347366-35-2
|
C23H26N2O3S
|
|
methyl 4-{[2-(2-chlorophenyl)-4-quinazolinyl]amino}benzoate
|
347366-43-2
|
C22H16ClN3O2
|
|
Carbonic acid, butyl 2-pyridinyl ester (9CI)
|
347367-40-2
|
C10H13NO3
|
|
Carbonic acid, 2-methylpropyl 2-pyridinyl ester (9CI)
|
347367-41-3
|
C10H13NO3
|
|
METHYL 2-(2-OXOPYRIDIN-1(2H)-YL)BENZOATE
|
347367-48-0
|
C13H11NO3
|
|
1-CARBAZOL-9-YL-3-[(FURAN-2-YLMETHYL)-AMINO]-PROPAN-2-OL
|
347368-28-9
|
C20H20N2O2
|
|
5-Octenal, 7-oxo-, (5E)- (9CI)
|
347376-13-0
|
C8H12O2
|
|
4-(2,2-DibroMoethenyl)-2-Methoxy-1-(phenylMethoxy)benzene
|
347377-09-7
|
C16H14Br2O2
|
|
(1R,5S,6R)-rel-5-(1-Ethylpropoxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylic Acid Ethyl Ester
|
347378-74-9
|
C14H22O4
|
|
LTV-1
|
347379-29-7
|
C26H20N2O5S
|
|
2-Pyrrolidinone, 1-(3-butenyl)-5-thioxo- (9CI)
|
347380-59-0
|
C8H11NOS
|
|
2-Pyrrolidinone, 1-[2-(1-cyclopenten-1-yl)ethyl]-5-thioxo-
|
347380-61-4
|
C11H15NOS
|
|
2,5-Pyrrolidinedithione, 1-[2-(1-cyclopenten-1-yl)ethyl]-
|
347380-73-8
|
C11H15NS2
|
|
3H-Pyrrolizine-3-thione,1,2,5,6-tetrahydro-(9CI)
|
347380-76-1
|
C7H9NS
|
|
7H-Cyclopenta[3,4]thieto[3,2-g]pyrrolizine-7-thione, octahydro- (9CI)
|
347380-77-2
|
C11H15NS2
|
|
4,7-Methano-1,3-dioxolo[4,5-c]pyridine-6-methanol,hexahydro-2,2-dimethyl-,(3aS,4R,6R,7R,7aR)-(9CI)
|
347381-66-2
|
C10H17NO3
|
|
4,7-Methano-1,3-dioxolo[4,5-c]pyridine-6-carboxylicacid,hexahydro-,methylester,(3aS,4R,6R,7R,7aR)-(9CI)
|
347381-83-3
|
C9H13NO4
|
|
2-[(1-phenyl-1H-pyrrol-2-yl)methylene]-1H-indene-1,3(2H)-dione
|
347385-10-8
|
C20H13NO2
|
|
(5E)-5-{[1-(4-bromophenyl)-1H-pyrrol-2-yl]methylidene}-1-(4-methylphenyl)pyrimidine-2,4,6(1H,3H,5H)-trione
|
347385-54-0
|
C22H16BrN3O3
|
|
1-[(2,2,2-TRICHLOROETHOXY)CARBONYL]-PYRROLIDINE-2-CARBOXYLIC ACID
|
347386-09-8
|
C8H10Cl3NO4
|
|
1-[(4-NITROBENZYLOXY)CARBONYL]-PYRROLIDINE-2-CARBOXYLIC ACID
|
347386-12-3
|
C13H14N2O6
|
|
1-[(2,2,2-TRICHLOROETHOXY)CARBONYL]-PIPERIDINE-2-CARBOXYLIC ACID
|
347386-19-0
|
C9H12Cl3NO4
|
|
3-({4-[(1-(3,5-dimethylphenyl)-2,4,6-trioxotetrahydro-5(2H)-pyrimidinylidene)methyl]-2-methoxyphenoxy}methyl)benzoic acid
|
347387-29-5
|
C28H24N2O7
|
|
2-Ethynyl-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane
|
347389-74-6
|
C8H13BO2
|
|
4,4,5,5-Tetramethyl-2-(1-propyn-1-yl)-1,3,2-dioxaborolane
|
347389-75-7
|
C9H15BO2
|
|
Ranibizumab
|
347396-82-1
|
C11H12N2O2
|
|
ethyl 3-{2,5-dimethyl-3-[(1-(3-methylphenyl)-4,6-dioxo-2-thioxotetrahydro-5(2H)-pyrimidinylidene)methyl]-1H-pyrrol-1-yl}benzoate
|
347397-47-1
|
C27H25N3O4S
|
|
ethyl 3-(3-{(E)-[1-(3-fluorophenyl)-2,4,6-trioxotetrahydropyrimidin-5(2H)-ylidene]methyl}-2,5-dimethyl-1H-pyrrol-1-yl)benzoate
|
347397-71-1
|
C26H22FN3O5
|
|
(5E)-5-{[1-(2-ethylphenyl)-2,5-dimethyl-1H-pyrrol-3-yl]methylidene}-1-(3-methylphenyl)pyrimidine-2,4,6(1H,3H,5H)-trione
|
347397-76-6
|
C26H25N3O3
|
|
Acetamide, N-hydroxy-N-[2-(1-piperidinyl)ethyl]-
|
347400-41-3
|
C9H18N2O2
|
|
Carbamic acid, [2-(dimethylamino)ethyl]hydroxy-, 1-methylethyl ester (9CI)
|
347400-42-4
|
C8H18N2O3
|
|
3,8-Dioxatricyclo[3.2.1.02,4]octane-6-carboxylicacid,(1R,2S,4R,5S,6R)-rel-(9CI)
|
347406-21-7
|
C7H8O4
|
|
4(1H)-Pyrimidinone,5-fluoro-1-methyl-(9CI)
|
347418-37-5
|
C5H5FN2O
|
|
4(3H)-Pyrimidinone,5-fluoro-3-methyl-(9CI)
|
347418-38-6
|
C5H5FN2O
|
|
Pyrimidine, 4-chloro-5-fluoro- (9CI)
|
347418-42-2
|
C4H2ClFN2
|
|
3,4-Difluoro-2,5-bis(trimethylsilyl)thiophene
|
347838-12-4
|
C10H18F2SSi2
|
|
2,5-Dibromo-3,4-difluorothiophene
|
347838-15-7
|
C4Br2F2S
|
|
Perfluoro-alpha-sexithiophene
|
347838-21-5
|
C24F14S6
|
|
1H-Benzimidazole-2-ethanol,1-ethyl-(9CI)
|
347839-25-2
|
C11H14N2O
|
|
BENZYL-D5 BENZOATE
|
347840-01-1
|
C14H7D5O2
|
|
BENZYL-D5 CINNAMATE
|
347840-02-2
|
C16H9D5O2
|
|
N,N-DIMETHYL-D6-GLYCINE HCL
|
347840-03-3
|
C4H4ClD6NO2
|
|
N-METHYL-D3-GLYCINE HCL
|
347840-04-4
|
C3H5ClD3NO2
|
|
SODIUM BUTYRATE-4,4,4-D3
|
347840-05-5
|
C4H4D3NaO2
|
|
DOXEPIN-D3 HCL (N-METHYL-D3)
|
347840-07-7
|
C19H19ClD3NO
|
|
2-METHYL-D3-SUCCINIC-2,3,3-D3 ACID
|
347840-08-8
|
C5H2D6O4
|
|
1-BROMOTETRADECANE-14,14,14-D3
|
347840-09-9
|
C14H26BrD3
|
|
2-CHLOROANILINE-4,6-D2
|
347840-10-2
|
C6H4ClD2N
|
|
3-CHLOROANILINE-2,4,6-D3
|
347840-11-3
|
C6H3ClD3N
|
|
1-CHLORO-2,4-DINITROBENZENE-3,5,6-D3
|
347840-12-4
|
C6ClD3N2O4
|
|
1,3-PROPANEDIAMINE-1,1,3,3-D4
|
347840-13-5
|
C3H6D4N2
|
|
TRIMETHYL-D6-AMINE HCL (DIMETHYL-D6)
|
347840-14-6
|
C3H4ClD6N
|
|
DL-MEVALONOLACTONE-4,4,5,5,6,6,6-D7
|
347840-19-1
|
C6H3D7O3
|
|
2-Bromo-3-{[tert-butyl(dimethyl)silyl]oxy}-6-hydroxybenzenecarbaldehyde
|
347840-64-6
|
C13H19BrO3Si
|
|
4-(3,4-DIMETHOXY-PHENYL)-5-METHYL-2 H-PYRAZOL-3-YLAMINE
|
347840-95-3
|
C12H15N3O2
|